Proteomic profiling of the endogenous peptides of MRSA and MSSA

Haixia Tu1, Fei Xu2, Yiwei Cheng3

  • 1Center of Pathology and Clinical Laboratory, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.

Peerj
|December 13, 2021
PubMed

Insights

This study characterized the endogenous peptides of methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). MSSA peptides are linked to immune response, while MRSA peptides are associated with antibiotic resistance and toxicity.

Area of Science:

  • Microbiology
  • Bacteriology
  • Proteomics

Background:

  • Staphylococcus aureus causes skin and soft tissue infections.
  • Methicillin-resistant S. aureus (MRSA) infections are more severe than methicillin-susceptible S. aureus (MSSA).
  • The physiological and metabolic regulation of MSSA and MRSA is not well understood.

Purpose of the Study:

  • To investigate the endogenous peptidome of MSSA and MRSA.
  • To identify differentially expressed peptides between MSSA and MRSA.
  • To explore the functional roles of these peptides in bacterial physiology and pathogenicity.

Main Methods:

  • Comparative analysis of the endogenous peptidome of MSSA and MRSA.
  • Identification and quantification of differentially expressed peptides using mass spectrometry.
  • Bioinformatic analysis to identify peptide motifs and associated functions.

Main Results:

  • 1,065 endogenous peptides were identified, with 435 differentially expressed.
  • 292 MSSA-abundant peptides and 35 MRSA-abundant peptides were found.
  • MSSA-abundant peptides feature a "VXXXK" motif and are involved in penicillin-binding and immune responses.
  • MRSA-abundant peptides are associated with antibiotic resistance and increased toxicity.

Conclusions:

  • The study provides a comprehensive characterization of the MSSA and MRSA peptidomes.
  • Findings offer insights into the functional regulation of drug resistance and pathogenicity in S. aureus.
  • This research serves as a resource for developing novel therapeutic strategies against S. aureus infections.